Phillip D Levy Selected Research

insulin-like growth factor binding protein-related protein 1

1/2022	Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study.
1/2020	Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea.
1/2020	Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Phillip D Levy Research Topics

Disease

33	Heart Failure 04/2022 - 08/2009
13	Hypertension (High Blood Pressure) 10/2020 - 09/2010
7	Dyspnea (Shortness of Breath) 01/2022 - 03/2015
3	Sepsis (Septicemia) 01/2022 - 05/2018
3	Hypotension (Low Blood Pressure) 01/2017 - 09/2012
3	Stroke (Strokes) 08/2013 - 11/2009
2	Myocardial Infarction 12/2021 - 01/2017
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2021 - 01/2021
2	Infections 01/2021 - 05/2006
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 05/2018
2	Atherosclerosis 10/2020 - 01/2019
2	Hemorrhage 03/2018 - 02/2016
2	Hypertensive Crisis 08/2017 - 07/2012
2	Wounds and Injuries (Trauma) 11/2015 - 11/2008
1	Acute Coronary Syndrome 04/2022
1	Bradycardia 12/2021
1	Non-ST Elevated Myocardial Infarction 12/2021
1	Substance-Related Disorders (Drug Abuse) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Chest Pain (Chest Pains) 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2021
1	Pulmonary Edema 04/2021
1	Vitamin D Deficiency 01/2021
1	Multiple Sclerosis 11/2020
1	COVID-19 11/2020
1	Septic Shock (Toxic Shock Syndrome) 05/2019
1	Body Weight (Weight, Body) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Cross Infection (Nosocomial Infection) 01/2018
1	Delirium 01/2018
1	Chronic Disease (Chronic Diseases) 06/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2017
1	Obesity 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Peripheral Arterial Disease 01/2017
1	Angioedema 10/2015
1	Kidney Diseases (Kidney Disease) 01/2015
1	Hyperkalemia 01/2015
1	Ischemic Stroke 08/2013

Drug/Important Bio-Agent (IBA)

9	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2011
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 06/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2018
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 03/2016
3	insulin-like growth factor binding protein-related protein 1IBA 01/2022 - 01/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 02/2010
3	Vitamin D FDA LinkGeneric 01/2021 - 01/2017
3	LigandsIBA 02/2018 - 03/2015
3	Pharmaceutical PreparationsIBA 02/2016 - 07/2012
2	Troponin T (Troponin T1)IBA 01/2022 - 01/2019
2	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2021 - 01/2017
2	ReninIBA 12/2019 - 01/2015
2	Natriuretic PeptidesIBA 01/2019 - 03/2016
2	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 02/2018 - 03/2015
2	Type 1 Angiotensin ReceptorIBA 02/2018 - 08/2017
2	DiureticsIBA 08/2016 - 01/2016
2	Nicardipine (Dagan)FDA LinkGeneric 08/2013 - 07/2012
2	Labetalol (Normodyne)FDA LinkGeneric 08/2013 - 07/2012
2	Soluble Guanylyl CyclaseIBA 03/2013 - 09/2012
1	TroponinIBA 04/2022
1	Cocaine (Cocaine HCl)IBA 12/2021
1	Heroin (Diamorphine)IBA 12/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 12/2021
1	Annexin A5IBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	LipidsIBA 10/2020
1	duramycinIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	anti-inhibitor coagulant complexIBA 03/2018
1	Warfarin (Coumadin)FDA LinkGeneric 03/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Enalaprilat (Vasotec)FDA LinkGeneric 12/2016
1	CalciumIBA 08/2015
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2015
1	RelaxinIBA 03/2015
1	Mineralocorticoid Receptor AntagonistsIBA 01/2015
1	AldosteroneIBA 01/2015
1	PotassiumIBA 01/2015
1	sodium zirconium cyclosilicateIBA 01/2015
1	ElectrolytesIBA 01/2015
1	AngiotensinsIBA 01/2015
1	Vasodilator Agents (Vasodilators)IBA 06/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2013

Therapy/Procedure

16	Therapeutics 01/2021 - 08/2009
4	Length of Stay 12/2021 - 03/2015
4	Patient Readmission 01/2019 - 09/2010
2	Resuscitation 01/2022 - 05/2019
2	Intravenous Infusions 04/2021 - 01/2019
2	Critical Care (Surgical Intensive Care) 05/2018 - 07/2012
1	Catheters 12/2021
1	Percutaneous Coronary Intervention 12/2021
1	Renal Dialysis (Hemodialysis) 04/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Patient Admission (Patient Admissions) 01/2019
1	Medication Errors (Medication Error) 01/2018
1	Transitional Care 02/2017
1	Patient Transfer (Patient Dumping) 02/2017
1	Continuous Positive Airway Pressure 01/2017
1	Blood Pressure Monitors 01/2016
1	Cardiac Rehabilitation 11/2015